Latest News about BMY
Recent news which mentions BMY
7 Innovator Stocks Primed for Exceptional Growth
October 10, 2023
From InvestorPlace
Why Shares of Lexicon Pharmaceuticals Are Up Tuesday
October 10, 2023
From Motley Fool
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 09, 2023
From Benzinga
Why Shares of Tango Therapeutics Are Dropping Monday
October 09, 2023
From Motley Fool
Bristol Myers Squibb Strengthens Oncology Portfolio With Mirati Therapeutics' $5B Deal
October 09, 2023
From Benzinga
S&P 500, Nasdaq Set For Bleak Start To Week As Middle East Tensions Dampen Risk-On Mood: Earnings, Inflation Data In Focus
October 09, 2023
From Benzinga
From $150 oil to no impact at all: What the surprise attack on Israel means to markets
October 09, 2023
From MarketWatch
Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 09, 2023
From Benzinga
Shares in weapons makers Lockheed Martin, RTX surge following surprise attack on Israel and other stocks on the move
October 09, 2023
From MarketWatch
From MarketWatch
2 Growth Stocks That Could Rocket Higher Before the End of 2023
October 08, 2023
From Motley Fool
Bristol-Myers Squibb Unusual Options Activity For October 06
October 06, 2023
Tickers
BMY
From Benzinga
Thinking Of Buying Alexandria Real Estate Equities? Here Are The Properties And Tenants You'd Add To Your Portfolio
October 05, 2023
From Benzinga
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
From Benzinga
Medicare drug price negotiations move forward with all drugmakers participating, White House says
October 03, 2023
From MarketWatch
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
October 02, 2023
From InvestorPlace
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
October 02, 2023
From InvestorPlace
From Benzinga
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
September 29, 2023
From MarketWatch
From Benzinga
3 Dividend Stocks to Buy and Hold Until Retirement
September 28, 2023
From Motley Fool
Bristol-Myers Squibb Unusual Options Activity For September 27
September 27, 2023
Tickers
BMY
From Benzinga
3 Artificial Intelligence (AI) Stocks That Could Soar More Than Nvidia, According to Wall Street
September 25, 2023
From Motley Fool
Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.
September 24, 2023
From InvestorPlace
Bristol Myers' Lead Cancer Drug Opdivo Regime Meets Primary Goal In Phase 3 Lung Cancer Study
September 22, 2023
Tickers
BMY
From Benzinga
Quant Ratings Updated on 98 Stocks
September 19, 2023
From InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
From Benzinga
Looking Into Bristol-Myers Squibb's Recent Short Interest
September 18, 2023
Tickers
BMY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.